Pleșea, R.M.; Riza, A.-L.; Ahmet, A.M.; Gavrilă, I.; Mituț, A.; Camen, G.-C.; Lungulescu, C.V.; Dorobanțu, Ș.; Barbu, A.; Grigorescu, A.;
et al. Clinically Significant BRCA1 and BRCA2 Germline Variants in Breast Cancer—A Single-Center Experience. Cancers 2025, 17, 39.
https://doi.org/10.3390/cancers17010039
AMA Style
Pleșea RM, Riza A-L, Ahmet AM, Gavrilă I, Mituț A, Camen G-C, Lungulescu CV, Dorobanțu Ș, Barbu A, Grigorescu A,
et al. Clinically Significant BRCA1 and BRCA2 Germline Variants in Breast Cancer—A Single-Center Experience. Cancers. 2025; 17(1):39.
https://doi.org/10.3390/cancers17010039
Chicago/Turabian Style
Pleșea, Răzvan Mihail, Anca-Lelia Riza, Ana Maria Ahmet, Ionuț Gavrilă, Andreea Mituț, Georgiana-Cristiana Camen, Cristian Virgil Lungulescu, Ștefania Dorobanțu, Adina Barbu, Andra Grigorescu,
and et al. 2025. "Clinically Significant BRCA1 and BRCA2 Germline Variants in Breast Cancer—A Single-Center Experience" Cancers 17, no. 1: 39.
https://doi.org/10.3390/cancers17010039
APA Style
Pleșea, R. M., Riza, A.-L., Ahmet, A. M., Gavrilă, I., Mituț, A., Camen, G.-C., Lungulescu, C. V., Dorobanțu, Ș., Barbu, A., Grigorescu, A., Mirea, C. S., Schenker, M., Burada, F., & Streață, I.
(2025). Clinically Significant BRCA1 and BRCA2 Germline Variants in Breast Cancer—A Single-Center Experience. Cancers, 17(1), 39.
https://doi.org/10.3390/cancers17010039
